Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Feb 3, 2015

American Diabetes Association Announces Call for Pathway to Stop Diabetes Research Award Nominations
Feb 3, 2015

Sanofi and MannKind Announce Afrezza®, the Only Inhaled Insulin, Now Available in the U.S.
Jan 26, 2015

Sanofi and Regeneron Announce Praluent™ (alirocumab) Biologics License Application has Been Accepted for Priority Review by US FDA
Jan 20, 2015

Survey Shows Many People Living With Diabetes Are Uncertain About How to Properly Manage Hypoglycemia

Further education about hypoglycemia and routinely monitoring blood glucose levels is needed
- Photos 1
Jan 9, 2015

Sanofi and Regeneron Announce Positive Topline Results from First Phase 3 Trials Evaluating Monthly Dosing of Alirocumab in Patients with Hypercholesterolemia

- Primary efficacy endpoints met in two trials of alirocumab administered every four weeks -

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.